BIBDX
Price
$12.88
Change
+$0.05 (+0.39%)
Updated
Sep 4 closing price
Net Assets
1.04B
EPSKX
Price
$24.89
Change
+$0.10 (+0.40%)
Updated
Sep 5 closing price
Net Assets
811.67M
Interact to see
Advertisement

BIBDX vs EPSKX

Header iconBIBDX vs EPSKX Comparison
Open Charts BIBDX vs EPSKXBanner chart's image
BlackRock Global Dividend Instl
Price$12.88
Change+$0.05 (+0.39%)
VolumeN/A
Net Assets1.04B
NYLI Epoch Global Equity Yield
Price$24.89
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets811.67M
BIBDX vs EPSKX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BIBDX vs. EPSKX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIBDX is a Hold and EPSKX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIBDX has more cash in the bank: 1.04B vs. EPSKX (812M). BIBDX (1.24) and EPSKX (1.20) have matching dividends . BIBDX was incepted earlier than EPSKX: BIBDX (17 years) vs EPSKX (16 years). EPSKX (1.93) is less costly to investors than BIBDX (0.80). BIBDX is a more actively managed with annual turnover of: 44.00 vs. EPSKX (18.00). EPSKX has a lower initial minimum investment than BIBDX: EPSKX (1000) vs BIBDX (2000000). EPSKX annual gain was more profitable for investors over the last year : 5.75 vs. BIBDX (1.61). EPSKX return over 5 years is better than : 62.21 vs. BIBDX (17.29).
BIBDXEPSKXBIBDX / EPSKX
Total Expense Ratio0.801.8443%
Annual Report Gross Expense Ratio0.801.9341%
Fund Existence17 years16 years-
Gain YTD9.40914.88563%
Front LoadN/AN/A-
Min. Initial Investment20000001000200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B812M128%
Annual Yield % from dividends1.241.20103%
Returns for 1 year1.615.7528%
Returns for 3 years36.4844.0583%
Returns for 5 years17.2962.2128%
Returns for 10 years38.9253.4473%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOLT5.190.35
+7.23%
Bolt Biotherapeutics Inc
IAC37.190.40
+1.09%
IAC
DLTR101.120.87
+0.87%
Dollar Tree
BCAX12.06N/A
N/A
Bicara Therapeutics Inc.
SERA3.34-0.07
-2.05%
Sera Prognostics